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Abstract We have reported a novel serine protease produced by
Sarcophaga peregrina (Nakajima et al., J. Biol. Chem. 272
(1997) 23805^23810). This 26-kDa protease showed antibacter-
ial activity against several bacteria. This activity was an intrinsic
characteristic of the enzyme protein and not directly related to its
protease activity, because treating the 26-kDa protease with
diisopropyl fluorophosphate had no appreciable effect on its
antibacterial activity. Unlike bovine trypsin, the 26-kDa protease
interacted with acidic phospholipids, suggesting that its anti-
bacterial activity is attributable to interaction with bacterial
membranes.
z 1998 Federation of European Biochemical Societies.
Key words: Serine protease; Antibacterial activity;
Metamorphosis; Insect; Yellow body
1. Introduction
In a previous study, we puri¢ed a novel serine protease with
a molecular mass of 26 kDa and signi¢cant sequence similar-
ity to bovine trypsin from Sarcophaga peregrina (£esh £y)
pupae [1]. We puri¢ed this protease as a protein that cross-
reacted immunologically with an anti-sarcotoxin IA antibody.
Sarcotoxin IA is a cecropin-type antibacterial protein pro-
duced by this insect [2].
Most larval tissues of holometabolous insects are known to
disintegrate during the pupal stage and new adult structures
develop from imaginal discs [3]. In dipteran insects such as
Sarcophaga, the larval mid-gut disintegrates and the adult
mid-gut develops during the pupal stage. This process pro-
ceeds in a temporary organ called the yellow body. Adult
mid-gut cells derived from imaginal islands on the larval
mid-gut surround the larval mid-gut to form a primordial
adult mid-gut, which swells to form the yellow body. The
larval mid-gut encapsulated in the yellow body disintegrates
in situ and the yellow body itself extends to form an adult
mid-gut with development of adult structure. As the 26-kDa
protease gene was activated transiently during the pupal stage
and the protease was detected selectively in the yellow body,
this protease probably participates in larval mid-gut disinte-
gration [1].
During metamorphic mid-gut remodeling, the normal £ora
living in the larval mid-gut is believed to be killed and even-
tually replaced by the adult £ora [4]. As an antibody against
sarcotoxin IA cross-reacted with the 26-kDa protease, we ex-
pected the 26-kDa protease to possess both antibacterial and
protease activities. We found that the 26-kDa protease exerted
signi¢cant bactericidal activity against certain bacteria, sug-
gesting that this novel protease is responsible for larval mid-
gut disintegration and, at the same time, kills the larval nor-
mal £ora that are dispersed in the yellow body when the larval
mid-gut disintegrates.
2. Materials and methods
2.1. Preparation of the 26-kDa protease and treatment with diisopropyl
£uorophosphate (DFP)
The 26-kDa protease was puri¢ed to homogeneity from Sarcophaga
pupae, as described previously [1]. In order to inactivate the 26-kDa
protease with DFP, puri¢ed enzyme (14.2 Wg) was treated for 10 min
at 27‡C in 250 Wl 100 mM Tris-HCl bu¡er, pH 7.9, containing 1 mM
EDTA and 63 mM DFP. Control samples were treated identically,
but without DFP.
2.2. Assay of the antibacterial activity of the 26-kDa protease
Staphylococcus aureus (Cowan strain) was grown in tryptic soy
broth at 37‡C. Bacteria at the logarithmic phase were collected and
suspended at a density of 1U104 CFU/ml in 10 mM phosphate bu¡er,
pH 5.5. Bacterial suspension (180^360 Wl) and protease samples dis-
solved in the same bu¡er (20^40 Wl) were mixed and incubated for 1 h
at 37‡C. Then, 100 Wl each reaction mixture was plated onto a nu-
trient agar plate, incubated overnight at 37‡C, and the resulting bac-
terial colonies were counted. The antimicrobial speci¢city of the 26-
kDa protease was assayed essentially as described previously using
various bacteria and fungi [2]. The antimicrobial activity of the 26-
kDa protease was assessed by measuring the A650 value of the culture
medium in which each microorganism was growing.
2.3. Interactions of the 26-kDa protease with phospholipids
Multilamellar liposomes were prepared using the methods of Kin-
sky et al. [5]. Binding of the 26-kDa protease to liposomes was as-
sessed by incubating the mixtures of liposome suspension and the 26-
kDa protease (1 Wg) at 27‡C for 10 min in 100 mM Tris-HCl bu¡er,
pH 7.9, containing 5 Wg/ml leupeptin. Then, each mixture was centri-
fuged at 100 000Ug for 10 min and the top 4/5 (supernatant fraction)
and the bottom 1/5 (precipitate fraction) were subjected to SDS-poly-
acrylamide gel electrophoresis to examine the free and liposome-
bound 26-kDa protease. Over 80% of each phospholipid was recov-
ered in the precipitate fraction.
3. Results
The 26-kDa protease was originally puri¢ed from an extract
of Sarcophaga pupae as a protein that cross-reacted immuno-
logically with an antibody against sarcotoxin IA [1]. Although
no signi¢cant sequence similarity between sarcotoxin IA and
the 26-kDa protease was found [1], we examined whether the
26-kDa protease possesses antibacterial activity. As respective
positive and negative controls, we used sarcotoxin IA and
bovine trypsin; the latter shows about 40% sequence identity
to the 26-kDa protease. As shown in Fig. 1, the 26-kDa pro-
tease, but not trypsin, exhibited signi¢cant bactericidal activ-
ity, like sarcotoxin IA, when S. aureus (Cowan strain) was
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used as an indicator bacterium and its ED50 value was about
0.2 Wg/ml under our assay conditions.
We examined the antibacterial speci¢city of the 26-kDa
protease by assessing inhibition of the growth of various mi-
croorganisms. As summarized in Table 1, Corynebacterium
bovis was very sensitive to this enzyme, but Escherichia coli
was resistant and the minimum inhibitory concentration
(MIC) was estimated to be over 75.5 Wg/ml under our assay
conditions. Candida albicans and Candida pseudotropicalis
were also resistant to this protease, suggesting that generally,
bacteria are more susceptible to it than fungi.
Although bovine trypsin was found to have no appreciable
bactericidal activity, the possibility remained that the bacter-
icidal activity of the 26-kDa protease was due to its protease
activity, i.e. the surface protein(s) of sensitive bacteria was
digested by the 26-kDa protease, resulting in cell death.
Therefore, we pretreated the 26-kDa protease with DFP to
inhibit the protease activity and then examined its bactericidal
activity. As shown in Fig. 2, both the DFP-treated and intact
26-kDa protease showed virtually identical bactericidal activ-
ities, although the protease activity of the former had been
abolished (inset). These results suggest that the antibacterial
activity of the 26-kDa protease is not due to its protease
activity, but is an intrinsic characteristic of the protein mole-
cule. In this series of experiments, we used puri¢ed 26-kDa
protease, but it is possible that the antibacterial activity was
due to some other substance(s) contaminating the protease
fraction. In order to exclude this possibility as far as possible,
we subjected the puri¢ed 26-kDa protease to reverse-phase
HPLC and assayed the protease and antibacterial activities
of each fraction to see whether they could be separated,
which, as shown in Fig. 3, they could not. The relative values
of the amount of protein, antibacterial activity and protease
activity in each fraction agreed well. Moreover, as reported
previously, only one amino-terminal residue was identi¢ed
when puri¢ed 26-kDa protease was subjected to amino acid
sequencing [1]. Therefore, we concluded that the 26-kDa pro-
tease itself possesses antibacterial activity.
In a previous study, we demonstrated that sarcotoxin IA
interacted with acidic phospholipids of bacterial membranes,
resulting in membrane disorganization and disruption of the
electrochemical membrane potential [6]. Therefore, we exam-
ined whether the 26-kDa protease interacted with phospholip-
ids by preparing multilamellar liposomes using phosphatidyl-
glycerol (PG), phosphatidylserine (PS), phosphatidylinositol
(PI), phosphatidylcholine (PC) and phosphatidylethanolamine
(PE) and examining binding of the 26-kDa protease to these
liposomes. It became clear that the 26-kDa protease bound
selectively to the acidic phospholipids, PG, PS and PI, but not
to the neutral phospholipids, PC and PE. A typical pattern of
interaction of the 26-kDa protease with PS is shown in Fig. 4.
No appreciable interactions between bovine trypsin and these
phospholipids were detected under the same conditions. These
results suggest that the antibacterial activity of the 26-kDa
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Fig. 1. Bactericidal activities of the 26-kDa protease, sarcotoxin IA
and bovine trypsin. Increasing amounts of test sample were incu-
bated with a ¢xed CFU of S. aureus (Cowan strain) and the num-
ber of viable cells in each relative to that of the control (treated
with bu¡er alone) was plotted. a, 26-kDa protease; E, bovine tryp-
sin; b, sarcotoxin IA.
Table 1
Antimicrobial speci¢city of the 26-kDa protease
Microorganism MIC value (Wg/ml)
Staphylococcus aureus (Cowan) 18.9
Staphylococcus aureus (Smith) 75.5
Corynebacterium bovis (1810) 2.4
Bacillus subtilis (PCI219) 18.9
Escherichia coli (NIH J) s 75.5
Salmonella typhi (T-63) 18.9
Candida albicans s 75.5
Candida pseudotropicalis s 75.5
Fig. 2. Bactericidal activity of the DFP-treated 26-kDa protease. Pu-
ri¢ed 26-kDa protease was treated with DFP and the bactericidal
activity was examined. DFP alone had no appreciable bactericidal
activity under these assay conditions. Inset: protease activity of 1 Wg
intact and DFP-treated 26-kDa protease in units (1 unit is the
amount that released 1 Wmol MCA). b, DFP-treated 26-kDa pro-
tease; a, intact 26-kDa protease.
Fig. 3. Reverse-phase HPLC of puri¢ed 26-kDa protease. Puri¢ed
26-kDa protease was subjected to reverse-phase HPLC using a C18
column, the amount of protein, protease activity and antibacterial
activity in each fraction were determined and their values relative to
those of fraction 14 were plotted. a, Protease activity; b, antibacte-
rial activity; column, amount of protein.
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protease is due to its interaction with bacterial membranes, as
it does not seem to enter bacterial cells.
4. Discussion
We found that the 26-kDa protease puri¢ed from Sarco-
phaga pupae possesses antibacterial activity. We expected this
would be the case because we found that this protease cross-
reacted immunologically with an antibody against sarcotoxin
IA. Sarcotoxin IA is an antibacterial protein comprising 39
amino acid residues produced by this insect [7]. However, as
reported previously, no signi¢cant sequence identity between
sarcotoxin IA and the 26-kDa protease was found, suggesting
that this antibody recognized an epitope in the 26-kDa pro-
tein with a similar secondary and/or tertiary structure to sar-
cotoxin IA. There seem to be two possible situations: one is
that the epitope in the 26-kDa protease that reacts with the
antibody against sarcotoxin IA is in fact crucial for its anti-
bacterial activity, and the other is that its antibacterial activity
and antibody reactivity are not directly related. As reported
previously, sarcotoxin IA is very toxic to E. coli and C. bovis,
with MIC values usually below 1 Wg/ml [2]. However,
although C. bovis was sensitive, E. coli was rather resistant
to the 26-kDa protease. Therefore, it is too early to conclude
that the modes of action of the 26-kDa protease and sarco-
toxin IA are the same.
Recently, several serine proteases and proteins structurally
related to them were reported to possess bactericidal activity
and they were thought to play roles in the host defense mech-
anisms of various organisms [8,9]. Such molecules have been
named serprocidins and cathepsin G, elastase, protease-3 and
azurocidin are members of the serprocidin family. The amino
acid identity between the 26-kDa protease and cathepsin G
was about 31% [10]. We propose that the 26-kDa protease is
also a member of the serprocidin family. The 26-kDa protease
was found to be synthesized at a speci¢c developmental stage
of Sarcophaga, when remodeling of the mid-gut takes place in
the yellow body, and it was suggested to be involved in dis-
integration of the larval mid-gut in situ. The 26-kDa protease
may play a role in killing the normal £ora that is released
from the disintegrating larval mid-gut into the yellow body
and elimination of the larval £ora is a prerequisite for its
replacement by the adult £ora.
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Fig. 4. Binding of puri¢ed 26-kDa protease to PS liposomes. In-
creasing amounts of liposomes were mixed with 1 Wg puri¢ed 26-
kDa protease or bovine trypsin and kept at 27‡C for 10 min. After
centrifugation, the supernatant (top 4/5) and pellet (bottom 1/5)
fractions were subjected to SDS-polyacrylamide gel electrophoresis
to estimate the amount of protease recovered in each fraction. S and
P indicate the supernatant and pellet fractions, respectively.
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